Cardiomyocytes Market Outlook:
Cardiomyocytes Market size was valued at USD 5.99 billion in 2025 and is expected to reach USD 15.82 billion by 2035, registering around 10.2% CAGR during the forecast period i.e., between 2026-2035. In the year 2026, the industry size of cardiomyocytes is evaluated at USD 6.54 billion.
The market is thriving on the back of the rising incidence of cardiovascular diseases in the world. According to research an estimated 7% of men and around 4.5% of women suffer from heart-related diseases. The heart's rhythmic beating is regulated by cardiomyocytes, which are the cells that produce contractile force in an intact heart. Hence, increasing the demand for cardiomyocyte therapies in the world.
In addition to these, factors that are believed to fuel the market growth of the cardiomyocytes market include the growing geriatric population. Research shows that an estimated 771 million individuals worldwide were 65 years of age or older in 2022, making up about 10% of the world's population. This increases the demand for cardiomyocyte therapies as older people are more susceptible to cardiovascular diseases.
